Asia · Markets & Finance · CNBC-TV18

Gland Pharma to invest $21 million in US drugmaker, take 60% stake

Published by CNBC-TV18 · India 1 h ago

Gland Pharma will invest $21 million in its US subsidiary, which will acquire a 60% stake in newly incorporated Novelstar Pharma as the company expands in America.

Read the full article on CNBC-TV18 Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.cnbctv18.com)

Also worth reading

Mint

PB Fintech shares crash 48% in 6 sessions; stock back to IPO price - Should investors change strategy?

The Economic Times

Dividends or growth? EQDP fund managers say capital allocation is key to valuations

SCMP Business

Gland Pharma to invest $21 million in US drugmaker, take 60% stake

Share

Also worth reading

PB Fintech shares crash 48% in 6 sessions; stock back to IPO price - Should investors change strategy?

Helicopter crash in California kills 2, 1 missing

Why the operator of US’ biggest container port wants closer ties with Singapore

Airtel Money to raise £529 million in LSE IPO at £5.3 billion valuation

Dividends or growth? EQDP fund managers say capital allocation is key to valuations

Hong Kong needs new funding model to draw investment from global drug makers: AstraZeneca